- £57.66m
- £119.74m
- £195.19m
- 17
- 34
- 52
- 23
2019 November 30th | 2020 November 30th | R2021 November 30th | C2022 November 30th | 2023 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 224 | 189 | 206 | 214 | 195 |
Cost of Revenue | |||||
Gross Profit | 91.6 | 74.3 | 67.4 | 68.5 | 66.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 200 | 177 | 203 | 236 | 242 |
Operating Profit | 24.2 | 11.5 | 3.59 | -21.6 | -46.4 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 23.2 | 10.5 | 3.62 | -20.8 | -41.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 19.1 | 8.41 | 2.19 | -16.1 | -43.3 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 19.1 | 8.41 | 4.19 | -14.5 | -29.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 19.1 | 8.41 | 4.19 | -14.5 | -29.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.261 | 0.101 | 0.143 | 0.175 | -0.032 |
Dividends per Share |